Ameritas Investment Partners’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.1K | Hold |
4,797
| – | – | ﹤0.01% | 1983 |
|
|
2025
Q1 | $33.1K | Hold |
4,797
| – | – | ﹤0.01% | 2332 |
|
|
2024
Q4 | $25.4K | Hold |
4,797
| – | – | ﹤0.01% | 2529 |
|
|
2024
Q3 | $17.5K | Hold |
4,797
| – | – | ﹤0.01% | 2716 |
|
|
2024
Q2 | $13.1K | Buy |
+4,797
| New | +$13.1K | ﹤0.01% | 2818 |
|
|
2022
Q2 | – | Sell |
-3,310
| Closed | -$8K | – | 3267 |
|
|
2022
Q1 | $8K | Hold |
3,310
| – | – | ﹤0.01% | 2869 |
|
|
2021
Q4 | $12K | Hold |
3,310
| – | – | ﹤0.01% | 2848 |
|
|
2021
Q3 | $21K | Hold |
3,310
| – | – | ﹤0.01% | 2681 |
|
|
2021
Q2 | $33K | Hold |
3,310
| – | – | ﹤0.01% | 2457 |
|
|
2021
Q1 | $31K | Hold |
3,310
| – | – | ﹤0.01% | 2367 |
|
|
2020
Q4 | $16K | Hold |
3,310
| – | – | ﹤0.01% | 2594 |
|
|
2020
Q3 | $13K | Hold |
3,310
| – | – | ﹤0.01% | 2607 |
|
|
2020
Q2 | $15K | Hold |
3,310
| – | – | ﹤0.01% | 2519 |
|
|
2020
Q1 | $11K | Hold |
3,310
| – | – | ﹤0.01% | 2521 |
|
|
2019
Q4 | $14K | Hold |
3,310
| – | – | ﹤0.01% | 2603 |
|
|
2019
Q3 | $13K | Hold |
3,310
| – | – | ﹤0.01% | 2627 |
|
|
2019
Q2 | $15K | Hold |
3,310
| – | – | ﹤0.01% | 2620 |
|
|
2019
Q1 | $14K | Hold |
3,310
| – | – | ﹤0.01% | 2567 |
|
|
2018
Q4 | $11K | Hold |
3,310
| – | – | ﹤0.01% | 2637 |
|
|
2018
Q3 | $14K | Hold |
3,310
| – | – | ﹤0.01% | 2703 |
|
|
2018
Q2 | $12K | Buy |
+3,310
| New | +$12K | ﹤0.01% | 2790 |
|
|
2017
Q2 | – | Sell |
-2,230
| Closed | -$6K | – | 3054 |
|
|
2017
Q1 | $6K | Buy |
+2,230
| New | +$6K | ﹤0.01% | 2819 |
|